by The antibody discovery market involves the identification of antigen-specific antibody-producing cell clones using phage display libraries, hybridoma technologies, and yeast/bacterial cell-surface display methods. Antibodies play a crucial role in drug development processes for treating various conditions like cancer, cardiovascular diseases, and autoimmune disorders. They have high specificity and affinity for antigens and are being increasingly used to develop biologics.
The Antibody Discovery Market is estimated to be valued at USD 2.8 Bn in 2024 and is expected to reach USD 6.3 Bn by 2031, growing at a compound annual growth rate (CAGR) of 12.3% from 2024 to 2031.
Key Takeaways
Key players operating in the Antibody Discovery market are WuXi Biologics,GenScript,Genmab,Harbour BioMed,ImmunoPrecise.
The increasing research collaborations between biopharmaceutical companies and academic institutes provide significant opportunities for market players. The rising demand for affinity-based biologics will create scope for outsourcing antibody discovery research.
North America dominates the global antibody discovery market due to rising healthcare expenditure and presence of key market players in the region. However, Asia Pacific is expected to witness fastest growth fueled by improving R&D infrastructure and growing biotech industry in China and India.
Market Drivers
The rising incidence of chronic conditions such as cancer and cardiovascular diseases worldwide is a major factor driving the demand for antibodies in therapy development. According to WHO, cancer burden is expected to grow to 27 million new cases by 2040. Furthermore, supportive government policies for funding biomedical research and rise of custom antibody development services are boosting the antibody discovery market.
PEST Analysis
Political: Antibody discovery market is affected by government regulations and funding for healthcare and biotech research. Regulations around quality standards and ethics related to healthcare research can impact the market growth.
Economic: Growth of the antibody discovery market is dependent on economic conditions of key regions where majority of research spending takes place. Current global economic uncertainties may affect the industry spending on R&D activities in short term.
Social: Increasing awareness and acceptance of monoclonal antibody therapy is driving the social demand for new and better antibodies. Changes in lifestyle and consumption pattern related to illnesses also impact the type of antibody research undertaken.
Technological: Advent of new techniques like rational antibody design, in silico modeling, and high-throughput screening platforms is expediting the antibody discovery process. Automation and use of AI/ML is further improving efficiency and success rates of various stages involved.
The North American region accounts for the largest share of the global antibody discovery market in terms of value. This can be attributed to presence of major players and highest healthcare spending in the US and Canada. In terms of growth, Asia Pacific region is expected to witness the fastest CAGR during the forecast period due to rising investments in antibody R&D by Chinese and Indian biotech companies. Countries like China, Japan and South Korea are emerging biotech hubs.
The European region currently holds the second largest share of the global antibody discovery market. Majority of value is concentrated in countries like Germany, UK and France having well-established pharmaceutical industries and conducive regulatory environment for clinical research.
What Are The Key Data Covered In This Angio Suites Market Report?
:- Market CAGR throughout the predicted period
:- Comprehensive information on the aspects that will drive the Angio Suites’s growth between 2024 and 2031.
:- Accurate calculation of the size of the Angio Suites and its contribution to the market, with emphasis on the parent market
:- Realistic forecasts of future trends and changes in consumer behaviour
:- Angio Suites Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa
:- A complete examination of the market’s competitive landscape, as well as extensive information on vendors
:- Detailed examination of the factors that will impede the expansion of Angio Suites vendors
FAQ’s
Q.1 What are the main factors influencing the Angio Suites?
Q.2 Which companies are the major sources in this industry?
Q.3 What are the market’s opportunities, risks, and general structure?
Q.4 Which of the top Angio Suites companies compare in terms of sales, revenue, and prices?
Q.5 Which businesses serve as the Angio Suites’s distributors, traders, and dealers?
Q.6 How are market types and applications and deals, revenue, and value explored?
Q.7 What does a business area’s assessment of agreements, income, and value implicate?
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc.
